Welcome to our dedicated page for Medirom Healthcare Technologies SEC filings (Ticker: MRM), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
MEDIROM Healthcare Technologies Inc. filings document a foreign private issuer that reports to the SEC on Form 6-K and annual reports under Form 20-F. The company’s disclosures cover its Japan-based wellness salon operations, digital preventive healthcare products, ADR/ADS voting materials, and current reports furnished for press releases and material corporate events.
MRM filings include ordinary general meeting notices and proxy cards for common share and American Depositary Share holders, convertible-type corporate bond issuances under Japanese law, loan and maturity-extension agreements, registration statement incorporation references, KPI reporting changes, and partnership updates for World ID, Orb authentication, MOTHER Bracelet and REMONY. These records also describe capital structure, governance procedures, financing terms, risk language and foreign-issuer reporting mechanics.
Healthcare Technologies Inc. has refinanced maturing debt with a mix of new convertible bonds and a secured loan to its main lender, Kufu Company Holdings Inc. The company issued fourth unsecured convertible corporate bonds totaling JPY 275,000,000 at 5.0% interest, maturing on June 30, 2026, with an option to extend to December 25, 2026. These bonds can be converted into common shares at JPY 330 per share during a defined exercise period, instead of being repaid in cash. Separately, JPY 200,000,000 of the earlier bonds were refinanced into a loan bearing 10.0% interest and due March 31, 2026, secured by a pledge over all shares of subsidiary MOTHER Labs Inc. The remaining JPY 25,000,000 of the original bonds was repaid in cash.
Healthcare Technologies Inc. reported updated key performance indicators for December 2025. Its salon operation business served 70,499 customers, with record-high sales per customer of JPY 7,926 per visit and a repeat customer ratio of 77.8%, above the Japanese industry average sales per customer of JPY 4,806.
The company will shift from monthly to quarterly KPI disclosures starting with the December 2025 release. It also highlighted a compensated World ID initiative launched with Tools for Humanity and Hakuhodo Inc. and, in its Lav® health tech business, contracts with 102 corporate insurance associations and 12,398 cumulative app users as of December 2025.
Healthcare Technologies Inc. filed a Form 6-K after entering a Master Service Agreement with Tools for Humanity and the World Foundation to support adoption of World ID in Japan. The company plans to deploy Orb authentication devices across approximately 3,000 locations nationwide, a major expansion from an initially planned 100 locations.
Within its existing operations, Orbs are already installed at more than 150 Re.Ra.Ku wellness centres, with a goal of reaching about 300 centres across the Re.Ra.Ku Group. Beyond company-operated sites, Healthcare Technologies is negotiating with 370 third-party locations and intends to use a standard framework for contracts, branding, privacy protection, and quality control so authentication services are delivered consistently across partner locations.
MEDIROM Healthcare Technologies Inc. reported operational progress in its collaboration with World, a Proof of Human authentication protocol co-founded by Sam Altman and Alex Blania. The company announced that cumulative Proof of Human authentications using the World ID device “Orb” at its Re.Ra.Ku-centered stores in Japan surpassed 20,000 as of December 28, 2025, roughly doubling from 10,000 in about two months. This growth was largely driven by MEDIROM’s 25th anniversary “5-Minute Shoulder Massage Campaign for 250,000 People,” which paired free massage experiences with on-site human verification. MEDIROM plans to continue rolling out Orb devices to 200 salons nationwide, aiming to broaden access to this digital identity infrastructure while leveraging its existing wellness salon network.
MEDIROM Healthcare Technologies Inc. closed its previously announced sale and issuance of an aggregate principal amount of JPY400,000,000 of its Third Unsecured Convertible-Type Corporate Bonds with Share Options to 11 investors on December 12, 2025. Net proceeds are approximately JPY400,000,000, which the company plans to use for general corporate or financing purposes it deems appropriate from time to time.
The bonds were issued and sold outside the United States in reliance on Regulation S under the Securities Act of 1933. The bonds, the common shares issuable upon conversion, and any American Depositary Shares representing those shares have not been registered under U.S. securities laws and may not be offered or sold in the United States without registration or an applicable exemption. The company includes forward-looking statement cautions and incorporates this report by reference into its registration statements on Form S-8 and Form F-3.
Medirom Healthcare Technologies Inc. is issuing third unsecured convertible corporate bonds with share options totaling JPY 400,000,000 to 11 investors through a third-party allotment. The bonds carry a 2.0% annual interest rate from the day after issuance until June 30, 2026, with interest payable in two installments and the principal due on the maturity date, which the company may extend to December 25, 2026. Between December 12, 2025 and June 10, 2026, bondholders may convert bonds into common shares at a conversion price of JPY 343 per share, and the company also has rights to redeem, or repurchase with bondholder consent, before maturity. Medirom expects gross proceeds of JPY 400,000,000 and currently plans to use the funds for general corporate or financing purposes. The bonds are being sold outside the United States under Regulation S and are not registered under U.S. securities laws.
MEDIROM Healthcare Technologies Inc. (MRM) furnished a Form 6-K announcing it issued a press release about the Series A equity financing round of its subsidiary, MEDIROM MOTHER Labs Inc.
The company notes this information is furnished, not filed, and is not incorporated by reference except as specifically provided. The press release is included as Exhibit 99.1.
MEDIROM Healthcare Technologies Inc. announced that its Board of Directors approved adopting cryptocurrency as part of the company’s treasury strategy. The announcement is presented in a press release furnished as Exhibit 99.1 to this Form 6-K. The company states the information is furnished, not deemed “filed” under the Exchange Act, and is not incorporated by reference except as specifically provided.
MEDIROM Healthcare Technologies Inc. furnished a Form 6-K stating it issued a press release. The company announced a milestone of over 10,000 verifications using a new technological device at its wellness salons. The report notes the information is furnished, not deemed “filed,” and is not incorporated by reference except as specifically provided.
Medirom Healthcare Technologies Inc. furnished a Form 6-K for October 2025. The filing provides an interim report for the six months ended June 30, 2025 and related Inline XBRL files.
The company states that this Form 6-K, including its exhibits, is incorporated by reference into its Form F-3 registration statement (File No. 333-290161) and will form part of that registration statement unless superseded by later filings.